🎥✨ Martes de Divulgación Científica -16 de setiembre 2025 - Infección por Brevundimonas spp. - niños

Value of the Information & Strength of the Argument

The value of the information is high for clinicians, as it provides detailed clinical data on a rare pathogen and its management. The argumentation is solid, based on a peer-reviewed case report and supported by microbiological data. The speaker clearly explains the clinical decision-making process, including empirical therapy and escalation based on susceptibility testing. The discussion of prevention strategies is evidence-based, referencing a 2024 review on multimodal interventions. The presentation is well-structured and informative.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is good: the case report was published in a Scopus-indexed journal, and the speaker is a qualified infectious disease specialist. The sources cited include the case report itself and a 2024 review on infection control strategies. The title accurately reflects the content. The presentation is based on original data, and the speaker acknowledges limitations, such as the inability to identify the species in one case. The use of molecular methods for species identification adds to the rigor. The adequacy between title and content is excellent.

The title accurately reflects the content: a case report of Brevundimonas spp. infections in two immunocompromised children.

8/10

Presentation of a peer-reviewed case report published in a Scopus-indexed journal, with detailed clinical data and molecular identification. The speaker is an infectious disease specialist with relevant credentials. Limitations include the small number of cases and the lack of a control group.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and speaker presentation
• 02:00Case 1 presentation: patient history and clinical findings
• 05:00Case 1 treatment and evolution, including antibiotic escalation
• 08:00Case 2 presentation: patient history and clinical findings
• 10:00Case 2 treatment and evolution
• 12:00Microbiological characteristics of Brevundimonas spp.
• 15:00Discussion on treatment and susceptibility patterns
• 18:00Prevention strategies: hand hygiene, contact precautions, and environmental cleaning
• 20:00Conclusions and recommendations
• 22:00Q&A session: laboratory identification and transmission

• Case report: Infection by Brevundimonas spp. in immunocompromised children — The case report was published in this journal, which is indexed in Scopus.
• 2024 review on multimodal infection control strategies — Referenced in the presentation as a source for multimodal strategies to reduce multidrug-resistant organisms.

• Brevundimonas spp. infections in immunocompromised patients — The presentation aligns with existing literature on opportunistic infections in immunocompromised hosts.